Astilbin lowers the effective caffeine dose for decreasing lipid accumulation via activating AMPK in high-fat diet-induced obese mice.

Journal of the Science of Food and Agriculture
Licong YangGuodong Zheng

Abstract

Caffeine has an anti-obesity effect, although chronic excessive caffeine consumption also causes caffeinism, which is marked by increased anxiety or depression, amongst other symptoms. The present study aimed to investigate whether the addition of flavonoids such as astilbin can reduce the caffeine dose needed to inhibit obesity. ICR mice (n = 80) were fed with normal diet, high-fat diet (HFD), HFD supplemented with astilbin, caffeine, or astilbin + caffeine for 12 weeks. When diets supplemented with astilbin, 0.3 g kg-1 diet caffeine had the same effect as 0.6 g kg-1 diet caffeine alone, and 0.6 g kg-1 diet caffeine combined with astilbin most effectively inhibited HFD-induced obesity. Astilbin improved the anti-obesity effects of caffeine on lipid accumulation via the activation of AMP-activated protein kinase α (AMPKα). (i) Activated AMPKα decreased lipid biosynthesis by suppressing the activity or mRNA expression of 3-hydroxy-3-methylglutaryl-CoA reductase, sterol regulatory element binding protein 1c and its target gene fatty acid synthase. (ii) Activated AMPKα also up-regulated lipolysis by enhancing the expression of adipose triglyceride lipase and increasing the phosphorylation of hormone-sensitive lipase. (iii) Finally...Continue Reading

References

Mar 27, 1999·Biochemistry and Molecular Biology International·M LiW Tian
Feb 17, 2001·Gastroenterology·E C MunJ B Matthews
Aug 4, 2001·Biochemical and Biophysical Research Communications·Y SakakuraK Inoue
Mar 21, 2002·Journal of Agricultural and Food Chemistry·Nicolas LandraultPierre-Louis Teissedre
Nov 20, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·T MuraseI Tokimitsu
Dec 4, 2003·Biochemical Society Transactions·C Holm
Aug 31, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thomas WalleU Kristina Walle
Nov 20, 2004·Science·Robert ZimmermannRudolf Zechner
Jan 18, 2006·Cell·Joseph L GoldsteinMichael S Brown
May 23, 2006·The Journal of Pharmacology and Experimental Therapeutics·Dev K SinghTodd D Porter
Feb 23, 2007·Annual Review of Nutrition·Robin E DuncanHei Sook Sul
Nov 26, 2008·The American Journal of Cardiology·James A GreenbergRoy C Ziegelstein
Aug 1, 2009·Planta medica·Gui-Sheng LiFeng-Hua Fu
Dec 25, 2010·FEBS Letters·Julie Mantovani, Richard Roy
Mar 23, 2012·Nature Reviews. Molecular Cell Biology·D Grahame HardieSimon A Hawley
Jun 23, 2012·Nutrition·Sunil K PanchalLindsay Brown
Aug 10, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rohit A SinhaPaul M Yen
Nov 22, 2013·Journal of Agricultural and Food Chemistry·Qing-Feng ZhangYu-Xian Guo
Mar 7, 2015·The Journal of Toxicological Sciences·Zhenxing HeGuangming Li
Dec 17, 2016·Journal of Physiology and Biochemistry·Alfredo Fernández-QuintelaMaria P Portillo
May 3, 2019·Journal of Agricultural and Food Chemistry·Dan Zheng, Qing-Feng Zhang
May 15, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Abhishek SharmaPrerna Sharma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.